American Made Advocacy: There's No Substitute for American-made Microelectronics
It’s Only Common Sense: When Will Big Companies Start Paying Their Bills on Time?
The Chemical Connection: Troubleshooting PCB Process Problems
LPKF Opens Biolab for ARRALYZE Technology
December 6, 2021 | LPKFEstimated reading time: 1 minute
In its 45-year history, LPKF has repeatedly developed groundbreaking technologies and opened up new markets in the electronics, research and development, automotive and solar sectors. With ARRALZYE, the technology company has now developed a platform that will enable future customers in the biotechnology and pharmaceutical industries to perform single-cell screenings quickly and efficiently. ARRALYZE combines biomedical research with software and precision technology. The system can thus contribute to the accelerated development of personalized medicine, for example in the field of cancer therapies.
Dr. Robin Krueger is the head of ARRALYZE. He studied chemistry and biochemistry and worked early on with optically switchable proteins in hospital germs. "We know that tumors have individual characteristics and are influenced by genes and other physiological properties. For this reason, no one should get a standard cancer therapy, but one that is tailored to them personally." Krueger and his team of collaborators are convinced that ARRALYZE will make the development of modern medication much more cost-effective, thus enabling the widespread use of personalized medicine.
The recently opened biolab is equipped with specialized equipment for the production and analysis of cell cultures. "The biolab is essential for us to understand the needs and problems of our ARRALYZE customers and to be able to offer practical solutions," says Krueger. "This is what sets us apart from other plant growers in this complex field."
For Britta Schulz, member of the Management Board and head of the Development segment, the development of ARRALYZE technology in less than 3 years is a demonstration to LPKF's unwavering innovative strength. "With our LIDE technology for structuring glass and our expertise in optics, precision engineering and software, we are now bringing a product to market that will set new standards in biotechnology," says Schulz.
The system is thus one more step towards pushing back the previous boundaries of cell biology. The innovative approach of this process qualified ARRALYZE for inclusion in the shortlist of the prestigious Innovation Award 2021 of the State of Lower Saxony.
Share on:
Suggested Items
Indium Announces InnoJoin as Exclusive Global Sales Partner for NanoFoil®
11/04/2024 | Indium CorporationIndium Corporation announced that InnoJoin GmbH will be the exclusive global sales partner for NanoFoil® in component mounting applications. NanoFoil® is a leading nanotechnology material that delivers energy in a controlled and precise manner for joining, energetics, and heating applications.
Altus Sees Growing Interest for Laser Depanelling Solutions
11/04/2024 | Altus GroupAltus Group, a leading distributor of capital equipment in the UK and Ireland, has seen an increasing interest in laser depaneling systems from LPKF in 2024.
AMD and Fujitsu to Begin Strategic Partnership to Accelerate Open-Source AI Initiatives
11/01/2024 | AMDAMD and Fujitsu Limited today announced that they have signed a memorandum of understanding (MOU) to form a strategic partnership to create computing platforms for AI and high-performance computing (HPC). The partnership, encompassing aspects from technology development to commercialization, will seek to facilitate the creation of open source and energy efficient platforms comprised of advanced processors with superior power performance and highly flexible AI/HPC software and aims to accelerate open-source AI and/or HPC initiatives.
Biden-Harris Administration to Invest $825 Million in First CHIPS for America R&D Facility
11/01/2024 | U.S. Department of CommerceThe Department of Commerce and Natcast, the operator of the National Semiconductor Technology Center (NSTC), announced the expected location for the first CHIPS for America research and development (R&D) flagship facility. The CHIPS for America Extreme Ultraviolet (EUV) Accelerator, an NSTC facility (EUV Accelerator), is expected to operate within NY CREATES’ Albany NanoTech Complex in Albany, New York, supported by a proposed federal investment of an estimated $825 million. The EUV Accelerator will focus on advancing state of the art EUV technology and the R&D that relies on it.
CACI Completes Acquisition of Azure Summit Technology
10/31/2024 | BUSINESS WIRECACI International Inc. announced that it has completed its acquisition of Azure Summit Technology, a provider of innovative, high-performance radio frequency (RF) technology and engineering, focused on electromagnetic spectrum, in an all-cash transaction for $1.275 billion.